*ST Sailon: Announcement of Resolutions of the Third Extraordinary Shareholders Meeting in 2025
Securities code: 002898 Securities abbreviation: *ST Sailon Announcement Number: 2025-083 Sailon Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the Third Extraordinary Shareholders Meeting in 2025
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Special tips:
There are no changes, cancellations or vetoes to the resolutions at this shareholders’ meeting;
This shareholders’ meeting does not change the resolutions passed by previous shareholders’ meetings.
1. Meeting convening and attendance
1． Meeting status
(1) Meeting time:
On-site meeting: October 10, 2025 (Friday) 15:00
Online voting time: The specific time for online voting through the Shenzhen Stock Exchange trading system is 9:15-9:25 am, 9:30-11:30, and 13:00-15:00 pm on October 10, 2025; the specific time for online voting through the Shenzhen Stock Exchange Internet voting system is 9:15-15:00 on October 10, 2025.
(2) Meeting place: Company conference room on the 21st floor, Unit 2, No. 31, Nanwan North Road, Xiangzhou District, Zhuhai City. (3) Convening method: Convened by a combination of on-site voting and online voting.
(4) Meeting convener: the company’s board of directors.
(5) Meeting host: More than half of the directors jointly recommended Mr. Zhang Jianmin, the company’s independent director, to chair the meeting.
(6) Legality and compliance of the meeting: The convening, holding and voting procedures of this meeting complied with the provisions of the "Company Law", "Shenzhen Stock Exchange Stock Listing Rules" and other relevant laws, administrative regulations, departmental rules, normative documents and the "Articles of Association".
- Meeting attendance
(1) There were 70 shareholders and shareholders' authorized representatives present at the meeting, representing 41,078,115 shares, accounting for 40.5656% of the company's total voting shares. Among them: 2 shareholders passed on-site voting, representing 12,756,360 shares, accounting for 12.5972% of the company’s total voting shares. There were 68 shareholders voting online, representing 28,321,755 shares, accounting for 27.9684% of the company's total voting shares.
(2) 68 small and medium-sized shareholders (other than the company’s directors, senior managers and shareholders who individually or collectively hold more than 5% of the company’s shares) attended this meeting, representing 3,409,650 shares, accounting for 3.3671% of the company’s total voting shares. Among them: 1 small and medium-sized shareholder passed on-site voting, representing 100 shares, accounting for 0.0001% of the company’s total voting shares. There were 67 small and medium-sized shareholders voting online, representing 3,409,550 shares, accounting for 3.3670% of the company's total voting shares.
(3) The company’s directors and senior managers attended or attended this meeting. Beijing Kangda Law Firm witnessed the meeting and issued a legal opinion.
2. Proposal review and voting status
This shareholders' meeting reviewed various proposals in the meeting notice in accordance with the meeting agenda, and reviewed the following proposals through on-site voting and online voting:
- Review and adopt the "Proposal on Amending the Articles of Association"
Voting results:
40,986,415 shares were approved, accounting for 99.7768% of the total number of shares with valid voting rights present at this shareholders' meeting; 29,800 shares were opposed, accounting for 0.0725% of the total number of shares with valid voting rights present at this shareholders' meeting; 61,900 shares were abstained (of which 0 shares abstained by default due to non-voting), accounting for 0.1507% of the total number of shares with valid voting rights present at this shareholders' meeting.
Total voting results of small and medium shareholders:
3,317,950 shares were approved, accounting for 97.3106% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 29,800 shares were opposed, accounting for 0.8740% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 61,900 abstained shares (of which 0 shares abstained by default due to non-voting), accounting for 1.8154% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this shareholders’ meeting.
If the number of approved shares reaches more than two-thirds of the total number of shares with valid voting rights held by shareholders attending the meeting, the vote shall be passed.
- Review and adopt the "Proposal on Amending the Rules of Procedure of the General Meeting of Shareholders"
Voting results:
40,986,415 shares were approved, accounting for 99.7768% of the total number of shares with valid voting rights present at this shareholders' meeting; 29,800 shares were opposed, accounting for 0.0725% of the total number of shares with valid voting rights present at this shareholders' meeting; 61,900 shares were abstained (of which 0 shares abstained by default due to non-voting), accounting for 0.1507% of the total number of shares with valid voting rights present at this shareholders' meeting.
Total voting results of small and medium shareholders:
3,317,950 shares were approved, accounting for 97.3106% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 29,800 shares were opposed, accounting for 0.8740% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 61,900 abstained shares (of which 0 shares abstained by default due to non-voting), accounting for 1.8154% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this shareholders’ meeting.
If the number of approved shares reaches more than two-thirds of the total number of shares with valid voting rights held by shareholders attending the meeting, the vote shall be passed.
- Review and adopt the "Proposal on Amending the Rules of Procedure of the Board of Directors"
Voting results:
40,986,415 shares were approved, accounting for 99.7768% of the total number of shares with valid voting rights present at this shareholders' meeting; 29,800 shares were opposed, accounting for 0.0725% of the total number of shares with valid voting rights present at this shareholders' meeting; 61,900 shares were abstained (of which 0 shares abstained by default due to non-voting), accounting for 0.1507% of the total number of shares with valid voting rights present at this shareholders' meeting.
Total voting results of small and medium shareholders:
3,317,950 shares were approved, accounting for 97.3106% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 29,800 shares were opposed, accounting for 0.8740% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 61,900 abstained shares (of which 0 shares abstained by default due to non-voting), accounting for 1.8154% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this shareholders’ meeting.
If the number of approved shares reaches more than two-thirds of the total number of shares with valid voting rights held by shareholders attending the meeting, the vote shall be passed.
3. Legal opinions issued by lawyers
This shareholders' meeting was witnessed by lawyers Ji Yongjian and Wei Xianhao of Beijing Kangda Law Firm and issued legal opinions. The concluding opinion is: It has been verified that the convening and convening procedures of the company's shareholders' meeting comply with the provisions of laws, administrative regulations and the "Articles of Association", the qualifications of the attendees and the convener of the meeting are legal and valid, and the voting procedures and voting results of this shareholders' meeting are legal and valid.
4. Documents for reference
Resolution of the third extraordinary shareholders’ meeting of Sailong Pharmaceutical Group Co., Ltd. in 2025;
Legal opinion on the third extraordinary shareholders’ meeting of Sailong Pharmaceutical Group Co., Ltd. in 2025. Announcement hereby!
The Board of Directors of Sailon Pharmaceutical Group Co., Ltd.
October 11, 2025